Why 'digital twins' could speed up drug discovery
Briefly

Adsilico's synthetic hearts use AI to enhance medical device testing, capturing diverse patient anatomies and resulting in more inclusive and safer cardiovascular devices.
Our digital twins reflect not just biological attributes but also health conditions and ethnic backgrounds, addressing gaps in traditional clinical trials for device safety.
The hope is that AI-powered digital twins will significantly reduce the number of injuries and deaths caused by medical devices, which currently is alarmingly high.
Relying on computer-simulated tests to thoroughly evaluate medical devices provides a more cost-effective and efficient method than traditional clinical trials.
Read at www.bbc.com
[
|
]